Access to reperfusion therapy and mortality outcomes in patients with ST-segment elevation myocardial infarction under universal health coverage in Thailand

Table 3 Change in mortality with respect to one-percentage change in PCI recipients at the hospital level

* P < 0.001
^a Fixed-effects estimates based on the panel data analysis (n = 156 × 7 hospital-years) and 95% CI based on robust standard error
^b Conditional on the number of patients per hospital-year, but no further adjustment by baseline characteristics
^c Conditional on the number of patients per hospital-year and adjusted for covariates including patient characteristics (as % of patients): gender, age group (18–59, 60–69, 70–79, and > 80 years), length of hospital stay (1–2, 3–5, and > 6 days), and prior-year hospitalization with key comorbidities (CHF, CVD, CPD and RD)
CHF congestive heart failure; CI confidence interval; CPD chronic pulmonary disease; CVD cerebrovascular disease; PCI percutaneous coronary intervention; RD renal disease

ISSN: 1471-2261